Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors.

April 2, 2026 updated by: Riphah International University

Comparison Of Tele-Rehabilitation Versus Conventional Rehabilitation To Improve Cognition Among Stroke Survivor.

This study aims to:

  • Compare tele-rehabilitation and conventional rehabilitation for cognitive improvement after stroke.
  • Evaluate changes in cognitive function using standardized assessment tools.
  • Determine whether tele-rehabilitation is as effective as conventional therapy.
  • Improve evidence-based rehabilitation strategies for stroke survivors.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Stroke is a leading cause of long-term disability and is frequently associated with cognitive impairments affecting attention, memory, executive function, and processing speed, which significantly reduce independence and quality of life among survivors. Cognitive rehabilitation plays a vital role in promoting neuroplasticity and functional recovery after stroke. Conventional rehabilitation, delivered through face-to-face clinical sessions, remains the standard approach; however, tele-rehabilitation has emerged as an accessible and innovative alternative that allows structured cognitive interventions to be delivered remotely using digital platforms. Despite increasing use of tele-rehabilitation, limited comparative evidence exists regarding its effectiveness versus conventional rehabilitation for cognitive improvement in stroke survivors. This randomized controlled trial aims to compare the effectiveness of tele-rehabilitation and conventional rehabilitation over a 8-weeks intervention period. Participants will be randomly allocated into two groups receiving comparable intensity and frequency of cognitive rehabilitation. Cognitive outcomes will be assessed at baseline and post-intervention using standardized tools such as the Montreal Cognitive Assessment (MoCA) and other validated measures such as Stroop Test. The findings of this study will contribute to evidence-based rehabilitation practices and help determine whether tele-rehabilitation can provide an effective alternative to conventional cognitive rehabilitation following stroke.

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Pakistan
    • Punjab Province
      • Islamabad, Punjab Province, Pakistan, 44000
        • Recruiting
        • Riphah International University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults with age 50-80
  • Diagnosed with ischemic or hemorrhagic stroke within subacute to chronic phase.
  • Moca Score 10-25 score atleast
  • For tele-rehab must accessible to a digital device.

Exclusion Criteria:

  • History of neurodegenerative disorder e.g Alzheimer's Disease and Parkinson's Disease
  • Severe Cognitive Impairment
  • Lack of access to or inability to use a digital device

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tele-Rehabilitation Group
Participants will receive structured cognitive rehabilitation remotely through telecommunication platforms for 8 weeks. Sessions will be conducted with comparable frequency and intensity to the control group.
Behavioral: Tele-rehabilitation
Cognitive rehabilitation exercises delivered remotely using video-based sessions, targeting attention, memory, executive function, and processing speed. Sessions will be conducted over 8 weeks.
Active Comparator: Conventional Rehabilitation Group
Participants will receive face-to-face cognitive rehabilitation sessions in a clinical setting for 8 weeks with similar frequency and duration as the tele-rehabilitation group.
Behavioral: Conventional Rehabilitation
In-person cognitive rehabilitation exercises targeting attention, memory, executive function, and processing speed delivered in a clinical setting for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cognitive Function Measured by Montreal Cognitive Assessment (MoCA)
Time Frame: Baseline
The Montreal Cognitive Assessment (MoCA) will be used to assess global cognitive function, including attention, memory, executive function, language, and visuospatial abilities. Scores range from 0 to 30, with higher scores indicating better cognitive function.
Baseline
Change in Cognitive Function Measured by Montreal Cognitive Assessment (MoCA)
Time Frame: After 8 weeks
The Montreal Cognitive Assessment (MoCA) will be used to assess global cognitive function, including attention, memory, executive function, language, and visuospatial abilities. Scores range from 0 to 30, with higher scores indicating better cognitive function.
After 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Executive Function Measured by stroop Test
Time Frame: Baseline
The Stroop test will be used to assess selective attention, cognitive flexibility, and inhibitory control. Performance will be evaluated based on completion time and error rate.
Baseline
Change in Executive Function Measured by stroop Test
Time Frame: After 8 weeks
The Stroop test will be used to assess selective attention, cognitive flexibility, and inhibitory control. Performance will be evaluated based on completion time and error rate.
After 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Imran Amjad, Phd, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2026

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

August 15, 2026

Study Registration Dates

First Submitted

March 16, 2026

First Submitted That Met QC Criteria

March 25, 2026

First Posted (Actual)

March 31, 2026

Study Record Updates

Last Update Posted (Actual)

April 3, 2026

Last Update Submitted That Met QC Criteria

April 2, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/02263 Imran Amjad

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Tele-rehabilitation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe